APO-RISEDRONATE/Ca 35/1250 risedronate sodium 35 mg tablet and calcium carbonate 1250 mg tablet composite blister pack

Nchi: Australia

Lugha: Kiingereza

Chanzo: Department of Health (Therapeutic Goods Administration)

Viambatanisho vya kazi:

risedronate sodium, Quantity: 35 mg

Inapatikana kutoka:

Arrotex Pharmaceuticals Pty Ltd

INN (Jina la Kimataifa):

Risedronate sodium

Dawa fomu:

Tablet, film coated

Tungo:

Excipient Ingredients: iron oxide yellow; hypromellose; lactose; titanium dioxide; magnesium stearate; crospovidone; colloidal anhydrous silica; macrogol 8000; iron oxide red; hyprolose

Njia ya uendeshaji:

Oral

Vitengo katika mfuko:

Pack sizes of 7, 14, 28, 84, 112 tablets per pack

Dawa ya aina:

(S4) Prescription Only Medicine

Matibabu dalili:

Treatment of osteoporosis.,Treatment of glucocorticoid-induced osteoporosis. ,Preservation of bone mineral density in patients on long term corticosteroid therapy

Bidhaa muhtasari:

Visual Identification: Risedronate tablets are orange round biconvex coated tablets engraved APO on one side RIS above 35 on the other side; Container Type: Multiple containers; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Idhini hali ya:

Licence status A

Idhini ya tarehe:

2012-04-13